(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SPARK PATH SPARK THERAPEUTICS PIONEERING ACCESS TO HEALTHCARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SPARK PATH SPARK THERAPEUTICS PIONEERING ACCESS TO HEALTHCARE

ST13

US500000087812913

Class

36, 45

Filing

87812913

Registration

7369941

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

69

Latest update

06/11/2025

Trademark type

Word

Nice classes

36, 45

Filing date

02/27/2018

Registration date

04/30/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/30/2024

Last transaction

06/11/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/09/2018

First use in commerce

03/09/2018

Drawing code

4

Owner type

03

Owner location

Philadelphia, PA

Examiner

MORENO, PAUL

Law office

L30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Spark Therapeutics, Inc.

Representatives

Edward Frederick Behm SAUL EWING LLP

Technical classification

Nice Classes

Class 36Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

Providing information for patientsfamilies and health care providers about health care insurance coverageinsurance reimbursement programsinsurance payer policies and patient financial assistance programs

Class 45

Health care case management advice and consultation servicescare coordination for patients and families and providing adviceinformation and assistance to patients and their families in dealing with medical service providershospitalsinsurance companiesothers involved in patient care

Publications

History of USPTO decisions and trademark events.

69 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/04/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/04/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/04/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/13/2024

PUBO

PUBLISHED FOR OPPOSITION

02/13/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/24/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/29/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/27/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/27/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/18/2023

GNRT

NON-FINAL ACTION E-MAILED

04/18/2023

CNRT

NON-FINAL ACTION WRITTEN

04/18/2023

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

02/26/2023

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

12/13/2022

EXPT

EXPARTE APPEAL TERMINATED

11/29/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/29/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/27/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/26/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/26/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/10/2022

GNSL

LETTER OF SUSPENSION E-MAILED

06/10/2022

CNSL

SUSPENSION LETTER WRITTEN

06/10/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/29/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/29/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/27/2022

EXPI

EX PARTE APPEAL-INSTITUTED

04/27/2022

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

04/27/2022

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

04/27/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/27/2021

GNFR

FINAL REFUSAL E-MAILED

10/27/2021

CNFR

FINAL REFUSAL WRITTEN

10/27/2021

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

09/07/2021

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

01/26/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/25/2021

GNSL

LETTER OF SUSPENSION E-MAILED

01/25/2021

CNSL

SUSPENSION LETTER WRITTEN

01/25/2021

IUAA

USE AMENDMENT ACCEPTED

01/25/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/04/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/04/2021

ALIE

ASSIGNED TO LIE

12/28/2020

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

12/23/2020

IUAF

USE AMENDMENT FILED

12/23/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/22/2020

EAAU

TEAS AMENDMENT OF USE RECEIVED

12/22/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/22/2020

GNRT

NON-FINAL ACTION E-MAILED

06/22/2020

CNRT

NON-FINAL ACTION WRITTEN

06/22/2020

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/24/2020

ALIE

ASSIGNED TO LIE

01/31/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/23/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/23/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

07/16/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/11/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/11/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/05/2019

GNSL

LETTER OF SUSPENSION E-MAILED

01/05/2019

CNSL

SUSPENSION LETTER WRITTEN

01/05/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/14/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/13/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/13/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/13/2018

GNRT

NON-FINAL ACTION E-MAILED

06/13/2018

CNRT

NON-FINAL ACTION WRITTEN

06/13/2018

DOCK

ASSIGNED TO EXAMINER

06/12/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/06/2018

NWAP

NEW APPLICATION ENTERED

03/02/2018

Continuous trademark protection

Get notified about every new filing that threatens SPARK PATH SPARK THERAPEUTICS PIONEERING ACCESS TO HEALTHCARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.